{
  "id": 11320002,
  "title": "A Dynamics-Informed Machine Learning Framework for Inhibitor Optimization Against Quickly Evolving Targets to Avoid Resistance",
  "url": "https://urgent.news/2026/10/01/a-dynamics-informed-machine-learning-framework-for-inhibitor",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-01T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.09.25.754496v1?rss=1"
  },
  "original_language": "en",
  "account": "Drug resistance arises from mutations that alter protein conformational arrangements, diminishing inhibitor potency without breaking protein-ligand bonds. These mechanisms are challenging to discern, impeding the creation of inhibitors that maintain efficacy against rapidly mutating drug targets. To tackle this issue, researchers created ROBUST, a machine learning framework that incorporates experimental data, molecular dynamics simulations, and transparent statistical analysis to pinpoint the energy factors influencing inhibitor effectiveness. Focusing on the HIV-1 protease as a rigorous resistance model, the team measured 157 new inhibitor potency constants and combined them with existing data to form a thorough dataset of 364 protease-inhibitor pairs. By examining the corresponding molecular dynamics simulations, they identified a condensed network of energy interactions that effectively explain how resistance mutations and inhibitor alterations simultaneously modify molecular recognition and potency within the complex resistance terrain. Employing these energy signatures, the models derived from ROBUST accurately predicted binding free energies, achieving a root mean square error (RMSE) that signifies high predictive reliability.",
  "summary": "Drug resistance often emerges through mutations that reshape protein conformational ensembles, allowing inhibitor potency to be altered without directly disrupting protein-ligand contacts. Consequently, the molecular mechanisms underlying these effects remain difficult to identify, hindering the design of inhibitors with durable potency against rapidly evolving drug targets. To address this…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}